Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

CMTA

Clementia Pharmaceuticals Inc. (CMTA)

Clementia Pharmaceuticals Inc.
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CMTA
일자시간출처헤드라인심볼기업
2019/08/1521:30GlobeNewswire Inc.Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s BoardNASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/2921:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1919:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1822:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1201:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1201:00GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1001:40Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1001:29GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/3006:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/1322:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/1320:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0804:59PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0804:55PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803:25PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803:00PR Newswire (US)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803:00PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706:01PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706:01PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0206:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0204:15PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Clementia Pharmaceuticals, Inc.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0101:55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2620:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2620:30GlobeNewswire Inc.Clementia Announces Cancellation of Fourth Quarter and Year-End 2018 Financial Results and Conference CallNASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2606:26Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2522:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
 검색 관련기사 보기:NASDAQ:CMTA